VYNE Market Cap History



Below is a table of the VYNE market cap history going back to 7/30/2020:

Date VYNE Market Cap
7/30/2020275.01M
10/30/2020268.61M
2/16/2021424.73M
2/25/2021404.99M
4/15/2021280.57M
4/29/2021263.61M
8/6/2021134.45M
11/3/202176.00M
3/2/202231.17M
5/5/202224.21M
8/4/202223.90M
11/1/202215.50M
3/1/20239.73M
5/4/202323.98M
8/7/202315.45M
11/3/202342.29M
2/22/202430.59M

Also see: VYNE Shares Outstanding History
and VYNE YTD Return
VYNE Historical Market Cap:
-45.97% CAGR
VYNE Historical Market Cap: +-45.97% CAGR

Mouse over chart for data details
7/30/2020 ...2/22/2024
VYNE Therapeutics is a biopharmaceutical company that develops therapies for the treatment of immuno-inflammatory conditions. Co.'s primary program is VYN201, an administered pan-bromodomain and extra-terminal (BET) inhibitor to address diseases involving multiple inflammatory cell signaling pathways while providing low systemic exposure. Co.'s second program is VYN202, a BD2-selective oral small molecule BET inhibitor. VYN202 is in preclinical development for the treatment of immuno-inflammatory indications. FMX114 is Co.'s proprietary investigational combination gel formulation of tofacitinib and fingolimod that addresses both the source and cause of inflammation in atopic dermatitis. We show 17 historical shares outstanding datapoints in our VYNE shares outstanding history coverage, used to compute VYNE market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing VYNE market cap history over the course of time is important for investors interested in comparing VYNE's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of VYNE versus a peer is one thing; comparing VYNE market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like VYNE can fluctuate over the course of history. With this page we aim to empower investors researching VYNE by allowing them to research the VYNE market cap history.
Quotes delayed 20 minutes

Email EnvelopeFree VYNE Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
VYNE Therapeutics (VYNE) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

VYNT Market Cap History
WAT Market Cap History
WCG Market Cap History
WGS Market Cap History
WINT Market Cap History
WMGI Market Cap History
WST Market Cap History
XAIR Market Cap History
XBIO Market Cap History
XCUR Market Cap History
More Healthcare companies »

 

VYNE Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.